EGFR and cancer: Furthermore, NEDD4L has been proved to act as a tumor suppressor through regulating EGFR, TGFβ, and Wnt signaling pathways (67), and the lower NEDD4L level showed poor prognosis in a variety of cancers clinically (68, 69).